Skinvisible (SKVI) Other Non Operating Income (2012 - 2024)
Skinvisible's (SKVI) quarterly Other Non Operating Income came in at -$15072.0 in Q4 2024, down 3090.48% year-over-year from $504.0 in Q1 2024, and down 346.19% quarter-over-quarter from $6122.0 in Q3 2024.
Powered by 
Analysis
Skinvisible (SKVI) Other Non Operating Income (2012 - 2024) Analysis & Trends
Skinvisible has disclosed Other Non Operating Income across 11 years of filings, most recently posting -$15072.0 for Q4 2024.
- In Q4 2024, Other Non Operating Income fell 3090.48% year-over-year to -$15072.0; the TTM figure through Dec 2024 stood at -$3876.0 (up 21.14% YoY), while the FY2024 annual figure was -$3876.0, up 21.14% from the prior year.
- Other Non Operating Income came in at -$15072.0 for Q4 2024 at Skinvisible, down from $6122.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $288758.0 in Q4 2022 to a low of -$203503.0 in Q2 2021.
- Average Other Non Operating Income over 4 years is $16696.6, with a median of $2387.0 recorded in 2023.
- Year-over-year, Other Non Operating Income jumped 3995.28% in 2022 and tumbled 3090.48% in 2024.
- Over 4 years, Other Non Operating Income stood at $7051.0 in 2021, then jumped by 3995.28% to $288758.0 in 2022, then tumbled by 99.83% to $504.0 in 2023, then plunged by 3090.48% to -$15072.0 in 2024.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$15072.0 in Q4 2024, $6122.0 in Q3 2024, and $5854.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -15,072.00 |
| Sep 30, 2024 | 6,122.00 |
| Jun 30, 2024 | 5,854.00 |
| Mar 31, 2024 | -780.00 |
| Dec 31, 2023 | 504.00 |
| Sep 30, 2023 | -6,651.00 |
| Jun 30, 2023 | 4,270.00 |
| Mar 31, 2023 | -3,038.00 |
| Dec 31, 2022 | 288,758.00 |
| Sep 30, 2022 | 277.00 |
| Jun 30, 2022 | 8,518.00 |
| Mar 31, 2022 | 135,861.00 |
| Dec 31, 2021 | 7,051.00 |
| Sep 30, 2021 | 79,445.00 |
| Jun 30, 2021 | -203,503.00 |
| Mar 31, 2021 | -40,471.00 |
| Sep 30, 2019 | 157,226.00 |
| Jun 30, 2019 | -247,998.00 |
| Dec 31, 2018 | -191,957.00 |
| Sep 30, 2018 | -1.03 Mn |